Literature DB >> 14623084

Treponema denticola cystalysin catalyzes beta-desulfination of L-cysteine sulfinic acid and beta-decarboxylation of L-aspartate and oxalacetate.

Barbara Cellini1, Mariarita Bertoldi, Carla Borri Voltattorni.   

Abstract

Pyridoxal 5'-phosphate-dependent cystalysin from Treponema denticola catalyzes the beta-displacement of the beta-substituent from both L-aspartate and L-cysteine sulfinic acid. The steady-state kinetic parameters for beta-desulfination of L-cysteine sulfinic acid, k(cat) and K(m), are 89+/-7 s(-1) and 49+/-9 mM, respectively, whereas those for beta-decarboxylation of L-aspartate are 0.8+/-0.1 s(-1) and 280+/-70 mM. Moreover, cystalysin in the pyridoxamine 5'-phosphate form has also been found to catalyze beta-decarboxylation of oxalacetate as shown by consumption of oxalacetate and a concomitant production of pyruvate. The k(cat) and K(m) of this reaction are 0.15+/-0.01 s(-1) and 13+/-2 mM, respectively. Possible mechanistic and physiological implications are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623084     DOI: 10.1016/s0014-5793(03)01178-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  8 in total

1.  Folding pathway of the pyridoxal 5'-phosphate C-S lyase MalY from Escherichia coli.

Authors:  Mariarita Bertoldi; Barbara Cellini; Douglas V Laurents; Carla Borri Voltattorni
Journal:  Biochem J       Date:  2005-08-01       Impact factor: 3.857

2.  A novel 3-sulfinopropionyl coenzyme A (3SP-CoA) desulfinase from Advenella mimigardefordensis strain DPN7T acting as a key enzyme during catabolism of 3,3'-dithiodipropionic acid is a member of the acyl-CoA dehydrogenase superfamily.

Authors:  Marc Schürmann; Anika Deters; Jan Hendrik Wübbeler; Alexander Steinbüchel
Journal:  J Bacteriol       Date:  2013-01-25       Impact factor: 3.490

3.  Human wild-type alanine:glyoxylate aminotransferase and its naturally occurring G82E variant: functional properties and physiological implications.

Authors:  Barbara Cellini; Mariarita Bertoldi; Riccardo Montioli; Alessandro Paiardini; Carla Borri Voltattorni
Journal:  Biochem J       Date:  2007-11-15       Impact factor: 3.857

4.  Molecular Insight into the Synergism between the Minor Allele of Human Liver Peroxisomal Alanine:Glyoxylate Aminotransferase and the F152I Mutation.

Authors:  Barbara Cellini; Riccardo Montioli; Alessandro Paiardini; Antonio Lorenzetto; Carla Borri Voltattorni
Journal:  J Biol Chem       Date:  2009-01-20       Impact factor: 5.157

5.  Biochemical analyses are instrumental in identifying the impact of mutations on holo and/or apo-forms and on the region(s) of alanine:glyoxylate aminotransferase variants associated with primary hyperoxaluria type I.

Authors:  Elisa Oppici; Riccardo Montioli; Antonio Lorenzetto; Silvia Bianconi; Carla Borri Voltattorni; Barbara Cellini
Journal:  Mol Genet Metab       Date:  2011-10-05       Impact factor: 4.797

6.  A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2.

Authors:  Roman N Rodionov; Elisa Oppici; Jens Martens-Lobenhoffer; Natalia Jarzebska; Silke Brilloff; Dmitrii Burdin; Anton Demyanov; Anne Kolouschek; James Leiper; Renke Maas; Barbara Cellini; Norbert Weiss; Stefanie M Bode-Böger
Journal:  Sci Rep       Date:  2016-10-18       Impact factor: 4.379

7.  Crystal structure of the S187F variant of human liver alanine: glyoxylate [corrected] aminotransferase associated with primary hyperoxaluria type I and its functional implications.

Authors:  Elisa Oppici; Krisztian Fodor; Alessandro Paiardini; Chris Williams; Carla Borri Voltattorni; Matthias Wilmanns; Barbara Cellini
Journal:  Proteins       Date:  2013-06-01

8.  S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: an example of positive interallelic complementation.

Authors:  Riccardo Montioli; Alessandro Roncador; Elisa Oppici; Giorgia Mandrile; Daniela Francesca Giachino; Barbara Cellini; Carla Borri Voltattorni
Journal:  Hum Mol Genet       Date:  2014-07-02       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.